	Mar 2026	Dec 2025	Mar 2025	Change QoQ%	Change YoY%
Total Revenue Qtr	7.49	9.65	6.22	-22.4%	20.4%
Operating Profit Qtr	1.01	0.77	0.81	31.2%	24.7%
Net Profit Qtr	0.43	0.18	0.37	138.9%	16.2%
Earning Per Share Adjusted latest Qtr	1.31	0.54	1.12	142.6%	17.0%

* Standalone data

Detailed Results

Sharma East India Hospitals & Medical Research Ltd.

30 May 2026

103.05

-3.42%

Board Meeting

Sharma East India Hospitals & Medical Research Ltd - 524548 - Board Meeting Outcome for Outcome …

BSE India

Approval of audited financial results for the quarter and year ended 31st March 2026

pdf

Sharma East India Hospitals & Medical Research Ltd.

15 May 2026

103.05

-3.42%

Board Meeting

Sharma East India Hospitals & Medical Research Ltd - 524548 - Board Meeting Intimation for Approval …

BSE India

Sharma East India Hospitals & Medical Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider and approve the Standalone Audited Financial Results along with Auditor Report for the year ended March 31, 2026, pursuant to regulation 33 of SEBI (LODR) Regulation, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director.

pdf

Sharma East India Hospitals & Medical Research Ltd.

29 Apr 2026

103.05

-3.42%

Corp. Note

Sharma East India Hospitals & Medical Research Ltd - 524548 - Format of the Initial Disclosure …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySharma East India Hospitals & Medical Research Ltd 2CIN NO.L85110RJ1989PLC005206 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ms Bhawana Sharma Designation: Company Secretary cum compliance officer EmailId: bhawanasharma889@gmail.com Name of the Chief Financial Officer: Vimal Kumar Joshi Designation: Chief Financial Officer EmailId: sharmaeastindia@gmail.com Date: 29/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Sharma East India Hospitals & Medical Research Ltd.

11 Apr 2026, 02:31PM

103.05

-3.42%

Company Update

Sharma East India Hospitals & Medical Research Ltd - 524548 - Compliances-Certificate under Reg. 74 (5) …

BSE India

compliances certificate under Reg74(5) of SEBI(DP) Regulations, 2018 for the quarter ended ended 31-03-2026.

pdf

Sharma East India Hospitals & Medical Research Ltd.

27 Mar 2026

103.05

-3.42%

SAST

Sharma East India Hospitals & Medical Research Ltd - 524548 - Closure of Trading Window

BSE India

intimation for closure of trading Window

pdf

Sharma East India Hospitals & Medical Research Ltd.

16 Feb 2026

103.05

-3.42%

Company Update

Sharma East India Hospitals & Medical Research Ltd - 524548 - Announcement under Regulation 30 (LODR)-Newspaper …

BSE India

As per attachment.

pdf

Sharma East India Hospitals & Medical Research Ltd.

14 Feb 2026

103.05

-3.42%

Result

Sharma East India Hospitals & Medical Research Ltd - 524548 - Approval Of Unaudited Financial Results …

BSE India

approval of unaudited financial results for the quarter ended December 31 2025.

pdf

Sharma East India Hospitals & Medical Research Ltd.

14 Feb 2026

103.05

-3.42%

Board Meeting

Sharma East India Hospitals & Medical Research Ltd - 524548 - Board Meeting Outcome for Outcome …

BSE India

Approval of Standalone un-audited Financial Results for the quarter ended December 31 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015 along with limited review report.

pdf

Is Sharma East India Hospitals & Medical Research Ltd. worth buying?

4 Votes:

Buy 25.0%

Sell 25.0%

Hold 50.0%